Request Trial

Marisa Woutersen

Key details

Marisa Woutersen is a senior reporter for Life Sciences Intellectual Property Review and World IP Review. She largely covers intellectual property developments across the global life sciences sector, including pharmaceuticals, biotechnology, medtech, AI, M&A and regulation.

Since joining Newton Media in 2023, Marisa has reported across a wide range of topics, from the rise of generative AI and its impact on the creative industries to the crossover between intellectual property and sport, including issues affecting athletes, as well as global pharmaceutical disputes, vaccine technology, access to medicines and life sciences M&A.

She has reported live from court and regularly travels to international conferences, where she interviews lawyers, business leaders and other key industry figures.

Marisa holds a Master’s in International Law and a BA in Politics and International Relations from the University of Sussex, and is currently completing her NCTJ Diploma in Journalism.

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine search
Total results: 456

Articles by Marisa Woutersen

Scientists and IP: Avoiding the pitfalls of publishing research
Biotech
Scientists and IP: Avoiding the pitfalls of publishing research
Patent applications need to offer the full picture when it comes to scientific research, finds Marisa Woutersen at LSPN Europe.   30 November 2023
LSPN Spring: Life sciences cases taking centre stage at the UPC
Europe
LSPN Spring: Life sciences cases taking centre stage at the UPC
UPC judge, EPO director and Regeneron counsel shed light on the court’s dynamics at London event | Life sciences sector emerging as a major player in the court | Quality of rulings and tight timeframes blamed for lack of appeals.   28 November 2023
The personal touch: how to marry R&D and IP
Europe
The personal touch: how to marry R&D and IP
LSPN Europe delved into the challenges of aligning researchers goals with IP and legal frameworks | Disclosure forms, valuing relationships, incentivising researchers and education.   23 November 2023
Pharma
UPC judge and Regeneron counsel urge lobbying to improve court's transparency
Judge encourages lawyers and public to make their voices heard over transparency concerns | Awkward access to public hearings ‘causing problems’ says Regeneron counsel | Plea for public virtual hearings as judge notes that requests have been ‘coming in by the dozen’ | Panellists discuss at LSPN Europe.   23 November 2023
Americas
10x Genomics awarded $31m in key ruling over NanoString
District court’s verdict found NanoString infringed on seven patents related to protein detection tech | Marks the third victory for 10x Genomics in the last six months | NanoString ‘must drop the charade’ says 10x CEO.   21 November 2023
Americas
Cancer specialist to pay $83.4m over DNA sequencing infringement
TwinStrand Biosciences and the University of Washington win patent infringement case related to DNA mutation technology.   16 November 2023
Americas
Saxton & Stump adds senior tech counsel
New senior counsel joins IP group from previous roles at a Pittsburgh university, robotics company, and founding own law firm | Experience in patent prosecution in tech for life science sectors.   16 November 2023
Biotech
Neurocrine resolves dispute over Huntington's treatment
Neuroscience-focused biopharma ends litigation with four companies | Companies can introduce generic alternatives in the future.   14 November 2023
Biotech
Taiwan company fails to overturn PTAB decision over eye treatment patent
Federal Circuit rejects appeal in patent dispute with California’s Cloudbreak Theraputics | Court stated failure to prove concrete injury.   9 November 2023
Pharma
Court partially grants disqualification of PacBio’s legal team
Genomics company’s in-house attorney removed from case over links with patent infringement case | Court denied plaintiff’s motion to disqualify entire legal team.   7 November 2023

Not finding what you're looking for, please try resetting your applied search and filters,
or try the full site search.